Emerging topical onychomycosis therapies - quo vadis? - Wikidata - awgldk - TriplyDB

Emerging topical onychomycosis therapies - quo vadis?

Emerging topical onychomycosis therapies - quo vadis?

http://www.wikidata.org/entity/Q38268701

about

Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.

P2860

Q40753581-E5B7A8CE-607F-4618-8384-F651D552E893

P2860

Emerging topical onychomycosis therapies - quo vadis?

http://www.wikidata.org/entity/Q38268701

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Emerging topical onychomycosis therapies - quo vadis?

@en

type

label

Emerging topical onychomycosis therapies - quo vadis?

@en

prefLabel

Emerging topical onychomycosis therapies - quo vadis?

@en

P1433

Q38268701-F20E46E7-A497-446A-B822-D93850F614CE

P1476

Q38268701-E3018AA3-FCD3-4BDA-8CE5-F60048BE7191

P2093

Q38268701-5111DC5A-275D-4409-80D0-9B59D8DB9DBC

Q38268701-76A3B1A1-D660-479C-BB01-E849FAC04839

Q38268701-D71D62B3-FCE9-4AFF-95E8-EDA131C240AB

Q38268701-E7A0BECD-69F1-4418-AE28-6D7EB41EB5DE

P2860

Q38268701-0562399B-B004-4559-B24D-188A0A51D285

Q38268701-112BA903-1479-49FB-A275-CDC282BA9686

Q38268701-34F98AEC-3092-431E-BCF1-4382CF0DAD59

Q38268701-47956BD4-F1A2-4733-8C66-EA9D2315FA39

Q38268701-4ABAD4E7-AFF9-4EFE-80E2-4E2E1A1BEAE5

Q38268701-59DF43CA-4F60-4F75-BC41-9F3832093CAA

Q38268701-6A244174-C24F-4B53-BC27-BE5DE159BCED

Q38268701-99C1BF0B-DC26-4787-A262-46FA0AE012C7

Q38268701-B5EA177D-3249-482E-B232-028C5B5E487A

Q38268701-B6B643FA-C8F5-4F97-95FD-A4D1BF2F9E08

P304

Q38268701-5B8DD753-3B5C-4597-B083-8877D0C3EBAB

P31

Q38268701-5BA54192-137D-4602-ADE6-62B41AC8A71D

P356

Q38268701-A37F9B28-30F7-4B18-BD78-5C4B15B6A17E

P407

Q38268701-68A48D94-A51F-4A16-80F6-C61F4D189917

P433

Q38268701-C7D39F27-9C51-492F-BE38-521852BA6F6F

P478

Q38268701-3F45A665-26BA-4494-B641-D4B7399107A4

P577

Q38268701-38A6F357-9A0F-4875-97B6-3CAF77696733

P698

Q38268701-64209C61-4831-49CA-8C8E-3E7BBAD514B1

P356

14728214.2014.975206

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging topical onychomycosis therapies - quo vadis?

@en

P2093

Howard I Maibach

http://www.w3.org/2001/XMLSchema#string

Narasimha Murthy

http://www.w3.org/2001/XMLSchema#string

Rania Elkeeb

http://www.w3.org/2001/XMLSchema#string

Xiaoying Hui

http://www.w3.org/2001/XMLSchema#string

P2860

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

New therapeutic options for onychomycosis.

Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis.

Ungual and transungual drug delivery.

Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.

Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.

Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.

In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.

Transungual delivery of ketoconazole using novel lacquer formulation.

P304

489-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2014.975206

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25401504

http://www.w3.org/2001/XMLSchema#string